AAAAAA
Results: 26-31/31
Authors:
LIMENTANI SA
SAVIDGE GF",GIANGRANDE,"MARTINOWITZ UP
BERGMAN GE
WHITE GC
Citation: Sa. Limentani et al., DISCUSSION - FUTURE CONSIDERATIONS IN THE MANAGEMENT OF HEMOPHILIA-B, Acta haematologica, 94, 1995, pp. 59-59
Authors:
DJULBEGOVIC B
HANNAN M
BERGMAN GE
Citation: B. Djulbegovic et al., IS PROPHYLACTIC ANTICOAGULANT-THERAPY NECESSARY FOR HEMOPHILIA PATIENTS UNDERGOING ORTHOPEDIC SURGICAL-PROCEDURES, Blood, 84(10), 1994, pp. 10000200-10000200
Authors:
BERGMAN GE
Citation: Ge. Bergman, FACTOR-VIII INHIBITORS, Lancet, 342(8879), 1993, pp. 1109-1109
Authors:
SEREMETIS SV
ALEDORT LM
BERGMAN GE
BONA R
BRAY G
BRETTLER D
EYSTER ME
KESSLER C
LAU TS
LUSHER J
RICKLES F
Citation: Sv. Seremetis et al., 3-YEAR RANDOMIZED STUDY OF HIGH-PURITY OR INTERMEDIATE-PURITY FACTOR-VIII CONCENTRATES IN SYMPTOM-FREE HIV-SEROPOSITIVE HEMOPHILIACS - EFFECTS ON IMMUNE STATUS, Lancet, 342(8873), 1993, pp. 700-703
Authors:
SHAPIRO A
BERGMAN GE
Citation: A. Shapiro et Ge. Bergman, MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX - VIRAL SAFETY IN PUPS, Blood, 82(10), 1993, pp. 10000064-10000064
Authors:
MAUSERBUNSCHOTEN EP
VARON D
SAVIDGE GF
BERGMAN GE
Citation: Ep. Mauserbunschoten et al., EFFECTS OF CHRONIC USE OF MONOCLATE, PASTEURIZED IN PATIENTS WITH HEMOPHILIA-A PREVIOUSLY UNEXPOSED TO FACTOR-VIII CONCENTRATES OR OTHER BLOOD PRODUCTS, Blood, 82(10), 1993, pp. 10000153-10000153